Journey Medical Corporation
DERM
$6.33
$0.081.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -17.28% | -4.25% | -12.42% | 7.11% | -4.17% |
| Total Other Revenue | -- | -- | -- | -- | -100.00% |
| Total Revenue | -10.73% | -57.64% | -13.49% | 6.69% | -4.44% |
| Cost of Revenue | -0.49% | -17.79% | -15.78% | 5.69% | -70.87% |
| Gross Profit | -12.50% | -66.76% | -11.60% | 7.81% | 57.72% |
| SG&A Expenses | 2.23% | 31.96% | -14.93% | -36.65% | -29.64% |
| Depreciation & Amortization | -9.11% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.42% | 1.32% | -17.99% | 6.18% | -33.13% |
| Operating Income | 206.18% | -116.78% | 35.10% | -5.53% | 78.95% |
| Income Before Tax | 178.43% | -114.16% | 59.81% | -3.02% | 81.02% |
| Income Tax Expenses | -51.59% | -- | -- | -- | 869.23% |
| Earnings from Continuing Operations | 170.98% | -114.24% | 59.81% | -3.02% | 79.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 170.98% | -114.24% | 59.81% | -3.02% | 79.86% |
| EBIT | 206.18% | -116.78% | 35.10% | -5.53% | 78.95% |
| EBITDA | 349.42% | -111.52% | 38.62% | -9.23% | 85.30% |
| EPS Basic | 162.30% | -112.77% | 63.81% | 7.15% | 80.91% |
| Normalized Basic EPS | 168.84% | -118.67% | 42.00% | 7.17% | 82.01% |
| EPS Diluted | 156.68% | -115.00% | 63.81% | 7.15% | 80.16% |
| Normalized Diluted EPS | 168.84% | -121.33% | 42.00% | 7.17% | 82.01% |
| Average Basic Shares Outstanding | 14.00% | 11.52% | 11.05% | 10.95% | 5.44% |
| Average Diluted Shares Outstanding | 14.00% | -2.36% | 11.05% | 10.95% | 5.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |